论文部分内容阅读
FDA已经批准辉瑞公司的复方制剂 Caduet(苯磺酸氨氯地平/阿伐他汀钙)同时用于治疗高血压及高血脂 这是目前首个可以同时治疗2种适(?)证的药物,已有3700多例同时患高血压及高血脂的患者进行Caduet的临床试验。最近的临床试验
FDA Approves Pfizer’s Compound Caduet (Amlodipine besylate / Atorvastatin Calcium) for the Treatment of Hypertension and Hyperlipidemia This is the first drug that can treat 2 concurrent indications More than 3,700 patients with both hypertension and hyperlipidemia undergo a Caduet clinical trial. Recent clinical trial